Skip to contentGreen Jeremy — FATE THERAPEUTICS INC insider: 182 transactions · InsiderLensGreen Jeremy
- 10% owner at RayzeBio, Inc. · on record since Sep 21, 2023
- Former 10% Owner and Director at Lifesci Acquisition II Corp. · on record since Mar 13, 2024
- Director at Atara Biotherapeutics, Inc. · on record since May 23, 2025
- 10% owner at Verve Therapeutics, Inc. · on record since Jun 23, 2021
- 10% owner at ADC TELECOMMUNICATIONS INC · on record since Apr 2, 2026
- Director at FATE THERAPEUTICS INC · on record since Apr 22, 2026
- 10% owner at FATE THERAPEUTICS INC · on record since Apr 22, 2026
- 10% owner at ARRAY BIOPHARMA INC · on record since Aug 28, 2015
- 10% owner at Syros Pharmaceuticals, Inc. · on record since Jun 29, 2016
- 10% owner at AMICUS THERAPEUTICS INC · on record since Jun 13, 2016
- Officer at FATE THERAPEUTICS INC · on record since Dec 19, 2017
- 10% owner at Xeris Biopharma Holdings, Inc. · on record since Jun 27, 2018
- Director at ALDER BIOPHARMACEUTICALS INC · on record since Apr 26, 2018
- 10% owner at Gritstone Oncology, Inc. · on record since Sep 27, 2018
- 10% owner at Replimune Group, Inc. · on record since Jul 25, 2018
- 10% owner at Allakos Inc. · on record since Jul 24, 2018
- 10% owner at FELAFEL CORP · on record since Nov 16, 2018
- 10% owner at TCR2 THERAPEUTICS INC. · on record since Feb 21, 2019
- 10% owner at ALDER BIOPHARMACEUTICALS INC · on record since Mar 6, 2019
- 10% owner at Akero Therapeutics, Inc. · on record since Jun 24, 2019
- 10% owner at Stoke Therapeutics, Inc. · on record since Jun 24, 2019
- 10% owner at Atreca, Inc. · on record since Jun 24, 2019
- 10% owner at REDHOOK ALE BREWERY INC · on record since Apr 24, 2019
- Director at IGM Biosciences, Inc. · on record since Sep 23, 2019
- 10% owner at IGM Biosciences, Inc. · on record since Sep 23, 2019
- 10% owner at Cabaletta Bio, Inc. · on record since Oct 29, 2019
- 10% owner at Aprea Therapeutics, Inc. · on record since Oct 8, 2019
- 10% owner at Beam Therapeutics Inc. · on record since Feb 11, 2020
- 10% owner at Repare Therapeutics Inc. · on record since Jun 25, 2020
- 10% owner at PLIANT THERAPEUTICS, INC. · on record since Jun 9, 2020
- 10% owner at SMI PRODUCTS INC · on record since Apr 6, 2020
- 10% owner at Nurix Therapeutics, Inc. · on record since Jul 30, 2020
- 10% owner at Kalaris Therapeutics, Inc. · on record since Jul 30, 2020
- 10% owner at Annexon, Inc. · on record since Jul 30, 2020
- 10% owner at Kymera Therapeutics, Inc. · on record since Aug 25, 2020
- Director at Smart-tek Solutions Inc · on record since Dec 28, 2020
- 10% owner at Smart-tek Solutions Inc · on record since Dec 28, 2020
- Director at Atlas Therapeutics Corp · on record since Nov 27, 2020
- 10% owner at Atlas Therapeutics Corp · on record since Nov 27, 2020
- Director at Malo Holdings Corp · on record since Oct 7, 2020
- 10% owner at Malo Holdings Corp · on record since Oct 7, 2020
- Director at Absci Corp · on record since Jul 28, 2021
- 10% owner at Absci Corp · on record since Jul 21, 2021
- 10% owner at ALLIED DEFENSE GROUP INC · on record since Aug 12, 2021
- 10% owner at Entrada Therapeutics, Inc. · on record since Oct 28, 2021
- 10% owner at Lifesci Acquisition II Corp. · on record since Oct 18, 2021
- Director at Lifesci Acquisition II Corp. · on record since Oct 12, 2021
- 10% owner at Zymeworks Inc. · on record since Oct 18, 2022
Insider trading activity of Green Jeremy
- Transactions on record
- 182
- since Aug 10, 2015
- Open-market buys
- 49
- $182.1M
- Open-market sells
- 10
- $20M
- Companies traded
- 22
- last filing Oct 28, 2025
Figures computed from official regulatory filings — methodology.
Companies where Green Jeremy has traded
- ADC TELECOMMUNICATIONS INC6 tx · $30.6M · Oct 28, 2025
- Smart-tek Solutions Inc16 tx · $62.6M · Aug 26, 2025
- IGM Biosciences, Inc.28 tx · $144.2M · Aug 15, 2025
- FATE THERAPEUTICS INC32 tx · $169.5M · Dec 26, 2024
- Malo Holdings Corp15 tx · $156.6M · Oct 4, 2024
- Lifesci Acquisition II Corp.9 tx · $49.7M · Mar 13, 2024
- Absci Corp2 tx · $1M · Mar 5, 2024
- Atlas Therapeutics Corp4 tx · $18.1M · Jul 6, 2022
- Nurix Therapeutics, Inc.2 tx · Jul 30, 2020
Track record of Green Jeremy
Statistical track record
Free- Open-market buys
- 53
- Last buy
- Oct 27, 2025
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of Green Jeremy
Co-insiders of Green Jeremy
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
2 tx · Jun 9, 2020
RedCo II Master Fund, L.P.ADC TELECOMMUNICATIONS INC +3
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Oct 28, 2025 | BuyD | 3,846,153 | 3.90 USD | $15M | SEC |
| Oct 28, 2025 | BuyD | 3,846,153 | 3.90 USD | $15M | SEC |
| Aug 26, 2025 | AwardD | 4,097,730 | — | — | SEC |
| Aug 26, 2025 | AwardD | 4,097,730 | — | — | SEC |
| Aug 15, 2025 | OtherD | -7,199,325 | — | — | SEC |
| Aug 15, 2025 | OtherD | -667,666 | — | — | SEC |
| Aug 15, 2025 | Other | -2,964,843 | — | — | SEC |
| Dec 26, 2024 | Sell | -341,633 | 1.68 USD | $573.9K | SEC |
| Dec 26, 2024 | OtherD | 116,261 | 8.40 USD | $976.6K | SEC |
| Dec 26, 2024 | OtherD | -56,331 | 1.68 USD | $94.6K | SEC |
| Dec 26, 2024 | Buy | 397,964 | 1.68 USD | $668.6K | SEC |
| Dec 26, 2024 | OtherD | -116,261 | 8.40 USD | $976.6K | SEC |
| Dec 26, 2024 | Other | 1,084,936 | 1.68 USD | $1.8M | SEC |
| Dec 26, 2024 | Other | -1,084,936 | 1.68 USD | $1.8M | SEC |
| Dec 16, 2024 | OtherD | -6,022 | — | — | SEC |
| Dec 16, 2024 | Other | 30,110 | — | — | SEC |
| Dec 13, 2024 | Buy | 50,000 | 2.28 USD | $114K | SEC |
| Dec 13, 2024 | Buy | 50,000 | 3.81 USD | $190.5K | SEC |
| Dec 13, 2024 | Buy | 50,000 | 3.81 USD | $190.5K | SEC |
| Dec 13, 2024 | Buy | 50,000 | 2.28 USD | $114K | SEC |
| Dec 6, 2024 | Other | -1,026,888 | 1.25 USD | $1.3M | SEC |
| Dec 6, 2024 | Sell | -133,371 | 1.25 USD | $166.7K | SEC |
| Dec 6, 2024 | Other | 1,026,888 | 1.25 USD | $1.3M | SEC |
| Dec 6, 2024 | Buy | 133,371 | 1.25 USD | $166.7K | SEC |
| Oct 4, 2024 | OtherD | -1,093,799 | — | — | SEC |